L-Prolinol → HCID 17848353, Verbindung
Reaktionsgleichung
[Cl:1][C:2]1[CH:3]=[C:4]([CH:28]=[CH:29][C:30]=1[O:31][CH3:32])[CH2:5][NH:6][C:7]1[C:12]([C:13](=[O:22])[NH:14][CH2:15][C:16]2[N:21]=[CH:20][CH:19]=[CH:18][N:17]=2)=[C:11]([O:23][CH3:24])[N:10]=[C:9](S(C)=O)[N:8]=1.[NH:33]1[CH2:39][CH2:38][CH2:37][C@H:34]1[CH2:35][OH:36]>>[Cl:1][C:2]1[CH:3]=[C:4]([CH:28]=[CH:29][C:30]=1[O:31][CH3:32])[CH2:5][NH:6][C:7]1[C:12]([C:13](=[O:22])[NH:14][CH2:15][C:16]2[N:21]=[CH:20][CH:19]=[CH:18][N:17]=2)=[C:11]([O:23][CH3:24])[N:10]=[C:9]([N:33]2[CH2:39][CH2:38][CH2:37][CH:34]2[CH2:35][OH:36])[N:8]=1Komponenten
3
Versuchsvorschrift
4-(3-Chloro-4-methoxybenzylamino)-5-[N-(2-pyrimidinylmethyl)carbamoyl]-6-methoxy-2-methylsulfinylpyrimidine (prepared in the above (4)) and L-prolinol is treated in the same manner as Example 321(5) to give 4-(3-chloro-4-methoxybenzylamino)-5-[N-(2-pyrimidinylmethyl)carbamoyl]-6-methoxy-2-(2-hydroxymethyl-1-pyrrolodinyl)pyrimidine as a colorless crystalline powder 88 mg. mp 153–154° C.
Aufarbeitung
- additionis treated in the same manner as Example 321(5)
Quellen und Nachweise
- ORD-Eintrag
- ord-c42d2c97cae449b8ade73f293e135398
- Quelldatensatz
- uspto-grants-2007_05
- Patentnummer
- US07220736B2
Notizen zur Reaktion
Wird geladen…